Two separate studies on MS-rats corroborate this hypothesis: one showing widespread cortical elevation of both BDNF and IGF-1 (Lee et al., 2012); another reporting elevated BDNF levels in the prefrontal cortex (Poleksic et al., 2021). Here, BDNF is linked to myeloid sarcoma.